Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project

Background and Objectives: The Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine has demonstrated excellent efficacy and safety in phase 3 trials. However, no dialyzed patients were included, and therefore safety data for this patient group is lacking. The aim of the study was to assess the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Polewska, Karolina, Tylicki, Piotr, Biedunkiewicz, Bogdan, Rucińska, Angelika, Szydłowska, Aleksandra, Kubanek, Alicja, Rosenberg, Iwona, Rodak, Sylwia, Ślizień, Waldemar, Renke, Marcin, Dębska-Ślizień, Alicja, Tylicki, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307559/
https://www.ncbi.nlm.nih.gov/pubmed/34357013
http://dx.doi.org/10.3390/medicina57070732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307559/
https://www.ncbi.nlm.nih.gov/pubmed/34357013
http://dx.doi.org/10.3390/medicina57070732

Ejemplares similares